Kim Smith-Whitley
Chief Tech/Sci/R&D Officer bei GLOBAL BLOOD THERAPEUTICS, INC.
Aktive Positionen von Kim Smith-Whitley
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.05.2021 | - |
| Sickle Cell Disease Association of America, Inc. | Director/Board Member | - | - |
| Director of Finance/CFO | - | - |
Karriereverlauf von Kim Smith-Whitley
Ausbildung von Kim Smith-Whitley
| George Washington University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
Sektoral
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
| Sickle Cell Disease Association of America, Inc. | |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Kim Smith-Whitley
- Erfahrung
